From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Megan Spychalla, PA-C: Developing a Successful CAR T-Cell Therapy Outpatient Program—Behind the Scenes at the Mayo Clinic

Interview With Sarah Jimenez, MSN, APN-BC, AGACNP, AOCNP: Launching a CAR T-cell Therapy Program

Interview With Sarah Jimenez, MSN, APN-BC, AGACNP, AOCNP: Improving Quality for Inpatient Hematologic Services

Interview With Meaghan Ryan, MSN, FNP-BC: One Center's Process for Administering Immune Effector Cells

Interview With Josh D. Epworth, ARNP: Cytokine Release Syndrome (CRS) Management, Part 2

Interview With Josh D. Epworth, ARNP: Cytokine Release Syndrome (CRS) Management, Part 1

Interview With Linda Ramsdell, MSN, FNP-BC, OCN: Administering CAR T-Cell Therapy in the Outpatient Setting

Interview With Sherry A. Adkins, RN, MSN, ANP-C: Program Operations

Interview With Maritza Alencar, DNP, MBA, APRN-BC, BMTCN: CAR T-Cell Therapy: The Advanced Practice Provider's Role

Interview With Kendra Yum, PharmD, BCOP, on CAR T-Cell Therapy: A Primer on Mechanisms of Action

Interview With Patricia Mangan, MSN, CRNP: CAR T-Cell Therapy: Adverse Events

Interview With Tiffany Richards, PhD, MS, ANP, AOCNP: The CAR T-Cell Therapy Patient Journey

CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available

B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections

Neurologic Toxicity Post-CAR T-Cell Therapy and CRS: Differentiating Symptoms and Individual Management

Fast Facts #12: BCMA Targets